Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
about
Practical application of the neuroregenerative properties of ketamine: real world treatment experienceComorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessDendritic Spines in Depression: What We Learned from Animal ModelsIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersPharmacological approaches to the challenge of treatment-resistant depressionIntermediate phenotypes and biomarkers of treatment outcome in major depressive disorderEmotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsDifferential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression PatientscAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in ratsThe Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/β-catenin signaling.Ketamine and phencyclidine: the good, the bad and the unexpected.Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.Investigational drugs in recent clinical trials for treatment-resistant depression.Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depressionRhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.Antidepressant action of HDAC inhibition in the prefrontal cortex.Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.Electron Microscopic Analysis of Hippocampal Axo-Somatic Synapses in a Chronic Stress Model for Depression.Previous Ketamine Produces an Enduring Blockade of Neurochemical and Behavioral Effects of Uncontrollable StressBDNF - a key transducer of antidepressant effects.Duality of Antidepressants and Neuroprotectants.Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressantsCasting a Wide Net: Role of Perineuronal Nets in Neural Plasticity.Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation.ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals.Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress.New use for an old drug: oral ketamine for treatment-resistant depression.Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Ketamine Treatment and Global Brain Connectivity in Major Depression.Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster miceLoneliness in Relation to Depression: The Moderating Influence of a Polymorphism of the Brain Derived Neurotrophic Factor Gene on Self-efficacy and Coping Strategies.The Planar Cell Polarity Transmembrane Protein Vangl2 Promotes Dendrite, Spine and Glutamatergic Synapse Formation in the Mammalian Forebrain.Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection.Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.Treatment resistant depression: A multi-scale, systems biology approach.Gut Microbiota and the Neuroendocrine System.Reduced Synapse and Axon Numbers in the Prefrontal Cortex of Rats Subjected to a Chronic Stress Model for Depression.Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.
P2860
Q26748766-0A2D51E6-114F-4E60-AD6A-73EF79608876Q26765501-6D23799B-F2B3-40E0-8EC3-967DF5BEAF91Q26765612-9D7F35E2-A1CD-4D51-8EB2-44CB0AD05170Q26769948-1C6D9FE8-58B3-46BD-8FA2-695F80AF0AA5Q26798241-5C906DAB-3275-46AF-8944-DA2E14877471Q26823991-1EFF0731-B7F1-4EEC-BDEC-DF51E5D2974CQ28073684-3BEE13FE-CF90-4958-9A7D-3FCD4D84C743Q28553391-714C7453-E2A8-485B-B031-2FAC59389D26Q28602109-883367D2-C68E-46AB-B473-31F832595D9DQ30373328-5914C93A-B732-4D87-ACB1-7152D2ADCF3CQ33574930-A65EF887-BC37-4B47-B343-EF1D47663BF5Q34480719-07CB07EF-F1DC-4B11-9676-5EDC703FE207Q34512818-2535C69E-E3DE-4301-A62D-4B3756238029Q34549390-B714CE71-79A5-4667-B26B-D6A8A550B0D8Q35449610-1ECCBDC0-E7F4-4D69-8097-0148ADE493C0Q35547596-23F1F1CA-C1E3-4979-8B95-A18F75CBA155Q35638873-9BA588E0-3A72-42F1-BE2D-56B3A6C3673FQ36002723-E46A056B-929E-4A88-AC0A-D298AA2A0E68Q36116085-7CDF77E3-30F8-4D1C-94AC-DE1F1F890501Q36431977-48AEC75D-02C8-428C-8CB0-CA3F3DF09B29Q36608239-C6217B4E-14D1-449A-A33F-55D41D2DEF71Q36944840-53CFA1AA-D126-4188-A29A-A5825B42C0B6Q37307160-8252C32A-5B75-4C79-B502-D1BECEF1DA50Q37444960-E1EDD2E0-31C2-47FA-9D8A-0541F31DBD8BQ38540329-FB36CA5B-CFEA-4F19-A76C-EF4FCB2A995AQ38647566-F86B4440-C291-4F4B-B960-30CCDE6A6186Q38818235-D6DFB3D1-27EB-4ED8-8408-9C3ABEDB6A4EQ38917733-68400702-8439-4421-8BE4-278F088951B1Q38924066-9CDC1056-DFC0-469D-9AD0-174B9837C666Q38954648-946090F8-B434-445B-A008-60D7C5F2A56BQ39413238-10B53F64-4C22-41C6-BDC4-17E728012594Q39435750-9E6D5E13-9702-439A-B448-B6664A4700E8Q41050624-776B85EF-3D67-476C-8E5A-F998071F3D3BQ41290196-B2C35075-2D0D-4B51-BD96-46D994512FE1Q41452493-0CDD6896-1119-4192-89E8-14A5BD0FF43CQ43086364-C69F6224-3030-477F-9D0A-D0E6F16E4229Q47569935-058FE60F-E2F7-4255-9E92-36BCC418146BQ47832545-5B2966D9-98E1-4044-94AD-E854397138F8Q49235221-9158D6B5-6C67-48DD-8BD6-F707846346DFQ49712840-DDCCFAC5-76E2-4821-AE88-2BB0E5AC0E22
P2860
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathophysiology of depression ...... matergic synaptic connections.
@ast
Pathophysiology of depression ...... matergic synaptic connections.
@en
Pathophysiology of depression ...... matergic synaptic connections.
@nl
type
label
Pathophysiology of depression ...... matergic synaptic connections.
@ast
Pathophysiology of depression ...... matergic synaptic connections.
@en
Pathophysiology of depression ...... matergic synaptic connections.
@nl
prefLabel
Pathophysiology of depression ...... matergic synaptic connections.
@ast
Pathophysiology of depression ...... matergic synaptic connections.
@en
Pathophysiology of depression ...... matergic synaptic connections.
@nl
P2860
P921
P1476
Pathophysiology of depression ...... matergic synaptic connections.
@en
P2093
Ronald S Duman
P2860
P577
2014-03-01T00:00:00Z